TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TARS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/25

12:43 pm

tars

Rating for TARS

Medium Report

Rating for TARS

Report

2/25

12:43 pm

tars

Rating for TARS

Medium Report

Rating for TARS

Report

2/25

09:23 am

tars

Rating for TARS

Medium Report

Rating for TARS

Report

2/25

09:23 am

tars

Rating for TARS

Medium Report

Rating for TARS

Report

12/11

06:29 am

tars

Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Low Report

Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Report

12/9

11:16 am

tars

Rating for TARS

Medium Report

Rating for TARS

Report

12/9

11:16 am

tars

Rating for TARS

Medium Report

Rating for TARS

Report

12/8

04:27 pm

tars

Tarsus Pharmaceuticals initiated with an Overweight at Barclays

Medium Report

Tarsus Pharmaceuticals initiated with an Overweight at Barclays

Report

12/8

04:27 pm

tars

Tarsus Pharmaceuticals initiated with an Overweight at Barclays

Medium Report

Tarsus Pharmaceuticals initiated with an Overweight at Barclays

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.